US pharmacy pricing
Where to Find the Cheapest Omlonti Price
Lowest price found · US pharmacies
$344.30/fill
for Omlonti, across the pharmacies in our data
US pharmacy prices — 0.002%
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
| $344.30Lowest | $347.30 | $500.00 | |
| $344.30Lowest | $347.30 | $500.00 | |
| $362.85 | $365.85 | $500.00 | |
| $365.00 | $365.00 | $500.00 | |
| $366.20 | $369.20 | $500.00 | |
| $370.01 | $373.01 | $500.00 | |
| $370.01 | $373.01 | $500.00 | |
| $371.60 | $374.60 | $500.00 | |
| $375.96 | $378.96 | $500.00 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Interchangeable forms
Per RxNorm (U.S. National Library of Medicine), these share the same active ingredient and strength as Omlonti.
Frequently asked questions
Is Omlonti (Omlonti) expensive if I don't have insurance?
Our most recent US pharmacy data shows a low of roughly $344.30 for Omlonti with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.
Does Omlonti have a generic equivalent?
Generic and brand-name pricing for Omlonti is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
How much will I pay for Omlonti with my insurance plan?
The cost of Omlonti with insurance depends entirely on your specific plan's formulary, coverage tiers, and copay structure. You should contact your insurance provider directly for details on whether Omlonti is covered and what your out-of-pocket responsibility would be. If your plan does not cover the medication, or if you have Medicare or Medicaid with a coverage gap, you may explore other savings options, such as pharmacy discount programs or manufacturer assistance, to help manage the expense.
Is there a generic equivalent for Omlonti?
No. Omlonti is the brand-name product developed by Ocuvex Therapeutics, and a generic version (omidenepag isopropyl) is not currently available on the market.